{"id":278,"date":"2026-03-05T10:22:48","date_gmt":"2026-03-05T10:22:48","guid":{"rendered":"https:\/\/medi-first-pharma.de\/?page_id=278"},"modified":"2026-03-18T10:03:06","modified_gmt":"2026-03-18T10:03:06","slug":"1-1-1-das-medifirst-prinzip","status":"publish","type":"page","link":"https:\/\/medi-first-pharma.de\/en\/1-1-1-das-medifirst-prinzip\/","title":{"rendered":"The MediFirst Principle"},"content":{"rendered":"
<\/div><\/div>
<\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

The MediFirst Principle<\/h1>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t
<\/div><\/div><\/div>
\n\t
\n\t\t
<\/div><\/div><\/div>\n\t\t\t
\n\t\t\t\t
<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

The MediFirst Principle our compass.<\/span><\/h2>\n<\/div>\n\n\n\n\n
\n\t

The right to the best possible care.<\/strong><\/p>\n

We address structural gaps in medicinal product supply - with scientific integrity and responsibility that becomes operationally visible.<\/p>\n

We regard access to the best possible medical care as a fundamental right. Patients deserve access to therapies that are evidence-based and sustainably viable in everyday practice. We consistently align our processes so that humanity and economic reason form a unity: Precisely managed care counteracts mistreatment, strengthens dignity and autonomy, and promotes the long-term stability of care structures.<\/p>\n

 <\/p>\n

A principle for the entire system. <\/strong>The MediFirst Principle is the timekeeper for the entire group. It synchronizes research and innovation by focusing on care-relevant questions. It strengthens quality and responsibility through clear governance, defined responsibilities, and traceable interfaces. And it drives our operational implementation in pharma and trade, because reliable logistics are an integral part of responsible patient care.<\/p>\n

Anyone who works with MediFirst chooses a system that does not only describe responsibility, but translates it into structures.<\/p>\n

For people. For evidence. For our future. <\/em><\/p>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t

<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

Our methodology: From supply needs to the specification.<\/span><\/h2>\n<\/div>\n\n\n\n\n
\n\t

Our reverse-engineering approach starts where care must be effective: with the concrete clinical need of patients. We translate real-world evidence into precise target profiles and build the value chain consistently backwards - from process design to realization. In doing so, we systematically build quality along the entire chain - with multiple quality controls at several points.<\/p>\n

This\u00a0reverse engineering<\/strong>\u00a0is our structural principle for reproducible and reliable care quality.<\/p>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t

<\/div><\/div>
<\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t
The MediFirst Quality Loop shows how we combine evidence, quality assurance, and distribution in a closed system.<\/h5>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div><\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

Vertikale Integration f\u00fcr Pr\u00e4zisionsmedizin:
\nEin geschlossener Kreislauf f\u00fcr verl\u00e4ssliche Therapiesicherheit<\/h2>\n<\/div>\n\n\n\n
<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
\n\t\t
\n\t\t\t
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t
\n\t\t\t\n
\n\t

Patient-centered development<\/h4>\n<\/div>\n\n\n\n\n
\n\t

We translate clinical real-world evidence into defined target profiles. From this, we derive the intended cannabinoid\/terpene profile as a pharmaceutical specification (reverse engineering)<\/p>\n<\/div>\n\n\n\n\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>

<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
\n\t\t
\n\t\t\t
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t
\n\t\t\t\n
\n\t

Proprietary research & genetics<\/h4>\n<\/div>\n\n\n\n\n
\n\t

MediFirst R&D and biotech units develop defined chemotypes as a controlled starting basis - aligned with the Swiss research axis (Innuana).\"<\/p>\n<\/div>\n\n\n\n\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>

<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
\n\t\t
\n\t\t\t
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t
\n\t\t\t\n
\n\t

Technological realization<\/h4>\n<\/div>\n\n\n\n\n
\n\t

Implementation is carried out via a qualified partner network under GACP\/GMP framework conditions - with controlled process parameters and documented interfaces.<\/p>\n<\/div>\n\n\n\n\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>

<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
\n\t\t
\n\t\t\t
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t
\n\t\t\t\n
\n\t

Pharmaceutical integrity<\/h4>\n<\/div>\n\n\n\n\n
\n\t

As the pharmaceutical entrepreneur, we take responsibility for QA\/QP governance: batch testing, specification conformity, and documented release along defined quality processes.<\/p>\n<\/div>\n\n\n\n\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>

<\/div><\/div>
<\/div> <\/div>
\n\t
\n\t\t
\n\t\t
\n\t\t\t
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t
\n\t\t\t\n
\n\t

Pharmaceutical logistics<\/h4>\n<\/div>\n\n\n\n\n
\n\t

Distribution under a GDP framework: documented handovers, traceability, and controlled supply-chain interfaces to the point of care - operationally connected to the HCP portal.<\/p>\n<\/div>\n\n\n\n\n\t\t<\/div> \n\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t

<\/div><\/div><\/div>
\n\t
\n\t\t
<\/div><\/div><\/div>\n\t\t\t
\n\t\t\t\t
<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

Evidence as a foundation. Impact as a benchmark<\/span><\/h2>\n<\/div>\n\n\n\n\n
\n\t

Research forms our organizationally anchored foundation. Every development step of our intentional science follows a clear therapeutic purpose. We invest specifically in knowledge and structures to secure scientifically sound and pharmaceutically stabilized progress that can stand as a robust standard in care.<\/p>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t

<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

The touchstone for every decision<\/span><\/h2>\n<\/div>\n\n\n\n\n
\n\t

We measure our success by the impact achieved: improved care practice, increased decision confidence for healthcare professionals, and stable care structures. Before every project, we ask one question: Does it serve clinical integrity and a responsible implementation? This yardstick protects our direction and the reliability of our system.<\/p>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t

\n\t\t
<\/div><\/div><\/div>\n\t\t\t
\n\t\t\t\t
<\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>","protected":false},"excerpt":{"rendered":"Das MediFirst Prinzip Das MediFirst Prinzip \u2013 unser Kompass. Das Recht auf bestm\u00f6gliche Versorgung. Wir adressieren strukturelle L\u00fccken in der Arzneimittelversorgung \u2013 mit wissenschaftlicher Integrit\u00e4t und einer Verantwortung, die operativ...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-278","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/pages\/278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/comments?post=278"}],"version-history":[{"count":30,"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/pages\/278\/revisions"}],"predecessor-version":[{"id":308,"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/pages\/278\/revisions\/308"}],"wp:attachment":[{"href":"https:\/\/medi-first-pharma.de\/en\/wp-json\/wp\/v2\/media?parent=278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}